A consensus statement outlining principles for the control of non-high-consequence infectious disease (HCID) mpox (monkeypox) in healthcare and other settings in the UK.
Public Health Wales
- Dounreay to take on 23 new apprentices
- Guidance: Volunteering with Natural England: how to get involved
- Transparency data: Military court centres court listings
- Guidance: Search for businesses who have signed the Armed Forces Covenant
- Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell?): review by two specialists is required for initiating valproate but not for male patients already taking valproate
- Update on 2 specialist review requirements for male patients already taking valproate
- Guidance: Explosives precursors and poisons licences: application guidance
- Growth boost to support more first time buyers
- Transparency data: County Court at Central London
- Transparency data: Royal Courts of Justice Cause List
A consensus statement outlining principles for the control of non-high-consequence infectious disease (HCID) mpox (monkeypox) in healthcare and other settings in the UK.
The Ministry of Justice’s BOLD programme partnered with the CDEI to undertake extensive public engagement about government data linking with affected groups and trusted intermediaries, and better understand the impact of the programme on those it might affect
A consensus statement outlining principles for the control of non-high-consequence infectious disease (HCID) mpox (monkeypox) in healthcare and other settings in the UK.
A consensus statement outlining principles for the control of mpox in healthcare and other settings in the UK.
The UK strategy for mpox control 2022 to 2023 outlines the UK’s 4 nation plan to continue reducing mpox transmission over the next 12 months.
The UK strategy for mpox control 2022 to 2023 outlines the UK’s 4 nation plan to continue reducing mpox transmission over the next 12 months.
The UK strategy for mpox control 2022 to 2023 outlines the UK’s 4 nation plan to continue reducing mpox transmission over the next 12 months.
A consensus statement outlining principles for the control of monkeypox in healthcare and other settings in the UK.
A consensus statement outlining principles for the control of monkeypox in healthcare and other settings in the UK.
A consensus statement outlining principles for the control of monkeypox in healthcare and other settings in the UK.
A consensus statement outlining principles for the control of monkeypox in healthcare and other settings in the UK.
A consensus statement outlining principles for the control of monkeypox in healthcare and other settings in the UK.
A consensus statement outlining principles for the control of monkeypox in healthcare and other settings in the UK.
Annual report and data tables from the UK Focal Point on Drugs on the national prevalence, impact, prevention and treatment of drug use.
A surveillance programme which looks at how children in Wales aged between 4 and 5 are growing.
The statistics detail the work of Newborn Hearing Screening Wales including the number of babies screened, results, and numbers referred for further investigation.
Prevalence in Wales of rare genetic and syndromic conditions in children.
Ministerial Departmental News
- PM's Office, 10 Downing Street
- Cabinet Office
- Department for Business, Innovation and Skills
- Department for Communities and Local Government
- Department for Culture, Media and Sport
- Department for Education
- Department for Environment, Food and Rural Affairs
- Department for International Development
- Department for Transport
- Department for Work and Pensions
- Department of Energy and Climate Change
- Department of Health
- Foreign and Commonwealth Office
- HM Treasury
- Home Office
- Ministry of Defence
- Ministry of Justice
- Northern Ireland Office
- Scotland Office
- Wales Office
- See all departments